Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 108 Lymphoma, Large B-Cell, Diffuse 97 Lymphoma 86 Precursor Cell Lymphoblastic Leukemia-Lymphoma 57 Lymphoma, Non-Hodgkin 37 Lymphoma, Follicular 37 Burkitt Lymphoma 36 Leukemia 31 Multiple Myeloma 29 Lymphoma, Mantle-Cell 26 Hodgkin Disease 25 Lymphoma, T-Cell, Peripheral 20 Lymphoma, Large-Cell, Immunoblastic 15 Lymphoma, Large-Cell, Anaplastic 15 Lymphoma, B-Cell, Marginal Zone 15 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13 Neoplasm Metastasis 13 Lymphoma, B-Cell 13 Leukemia, Lymphocytic, Chronic, B-Cell 12 Recurrence 11 Neoplasms, Plasma Cell 11 Immunoblastic Lymphadenopathy 11 Lymphoma, T-Cell 8 Dendritic Cell Sarcoma, Interdigitating 8 Blast Crisis 8 Neoplasms 7 Enteropathy-Associated T-Cell Lymphoma 7 Waldenstrom Macroglobulinemia 5 Primary Myelofibrosis 5 Myasthenia Gravis 5

Interventions

fexofenadine 1 Prednisone 1 Aprepitant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × ITCH × Prednisone × Clear all

NCT01683552 2012-09-12

AprepIt

Campus Bio-Medico University

Phase 2 Completed

ITCH

Data powered by HemOnc (CC BY 4.0) Colophon ⚡